Newamsterdam Pharma Company N.V. - (NAMS)'s 30-day implied volatility (IV30) was 48.2% at the close on October 21, 2026, down from 49.6% the day before, against a 52-week range of 31.4% to 111.2%. Its 20-day historical volatility was 54.8%.
Data as of October 21, 2026.